CN Stock MarketDetailed Quotes
002603 Shijiazhuang Yiling Pharmaceutical
- 16.31
- +0.14+0.87%
Market Closed Dec 27 15:00 CST
27.25BMarket Cap183.26P/E (TTM)
16.39High16.08Low131.79KlotVolume16.20Open16.17Pre Close214.31MTurnover0.96%Turnover Ratio20.16P/E (Static)1.67BShares24.1752wk High2.37P/B22.45BFloat Cap14.1652wk Low17.79Limit Up1.38BShs Float53.16Historical High14.55Limit Down1.92%Amplitude4.79Historical Low0.30Dividend TTM16.26Avg Price53.51KlotAsk1.84%Div YieldTTM100Lot Size74.77KlotBid
Shijiazhuang Yiling Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -25.76%6.37B | -32.19%4.6B | -35.89%2.52B | -17.67%10.32B | 7.91%8.57B | 21.99%6.79B | 44.56%3.93B | 23.88%12.53B | -2.04%7.95B | -5.59%5.57B |
| Operating revenue | -25.76%6.37B | -32.19%4.6B | -35.89%2.52B | -17.67%10.32B | 7.91%8.57B | 21.99%6.79B | 44.56%3.93B | 23.88%12.53B | -2.04%7.95B | -5.59%5.57B |
| Other operating revenue | ---- | 14.27%3.25M | ---- | -73.27%3.48M | ---- | -64.36%2.85M | ---- | 113.13%13.04M | ---- | 156.01%7.99M |
| Total operating cost | -12.97%5.72B | -18.86%3.98B | -13.10%2.16B | -9.80%8.72B | 5.70%6.58B | 14.62%4.9B | 16.31%2.49B | 12.93%9.67B | -7.39%6.22B | -10.74%4.28B |
| Operating cost | -11.26%2.97B | -17.36%2.15B | -11.21%1.22B | -2.92%4.41B | 10.82%3.34B | 23.65%2.6B | 29.96%1.38B | 23.35%4.54B | 3.89%3.02B | 1.03%2.1B |
| Operating tax surcharges | -16.03%92.54M | -8.56%71.96M | -3.89%44.32M | -33.58%135.13M | -11.46%110.22M | -7.89%78.69M | -4.21%46.12M | 46.99%203.45M | 16.40%124.49M | 9.96%85.43M |
| Operating expense | -20.00%1.67B | -29.30%1.08B | -22.41%567.76M | -17.00%2.7B | -3.74%2.09B | 3.06%1.52B | -2.10%731.73M | -5.10%3.26B | -22.34%2.17B | -27.71%1.48B |
| Administration expense | -8.21%395.05M | -7.97%271.38M | -17.51%138.16M | -3.30%592.04M | 21.97%430.36M | 28.06%294.89M | 39.37%167.48M | 23.23%612.22M | 1.65%352.84M | 4.50%230.27M |
| Financial expense | 171.42%25.66M | 262.67%17.17M | 1,603.45%8.44M | 32.37%26.37M | 80.26%9.45M | -41.13%4.73M | -91.07%495.21K | 15.02%19.92M | -80.78%5.24M | -13.90%8.04M |
| -Interest expense (Financial expense) | 10.02%28.47M | 26.85%20.04M | 58.06%9.55M | 15.11%38.9M | 12.91%25.87M | -0.55%15.8M | -26.68%6.04M | -0.53%33.8M | -43.71%22.91M | -16.53%15.89M |
| -Interest Income (Financial expense) | 67.32%-5.61M | 65.30%-4.07M | 74.67%-2.08M | -24.80%-16.09M | 7.74%-17.16M | -17.67%-11.73M | -127.02%-8.2M | 36.93%-12.9M | -13.80%-18.6M | 16.01%-9.97M |
| Research and development | -3.67%571.91M | -2.31%393.29M | 9.55%180.59M | -17.33%853.19M | 7.62%593.71M | 7.64%402.61M | 4.29%164.84M | 30.28%1.03B | 2.62%551.68M | 4.03%374.04M |
| Credit Impairment Loss | -68.24%-17.64M | -145.02%-6.71M | -315.75%-3.38M | -40.01%-23.7M | -156.05%-10.49M | -37.89%-2.74M | 605.36%1.57M | 55.11%-16.93M | 19.44%-4.1M | 11.84%-1.99M |
| Asset Impairment Loss | 70.61%-4.68M | 80.41%-3.12M | 89.28%-1.56M | 67.39%-35.36M | -528.23%-15.92M | -151.78%-15.92M | ---14.54M | -278.74%-108.43M | ---2.53M | ---6.32M |
| Other net revenue | -52.94%61.55M | -12.35%45.34M | 185.19%32.09M | 596.40%180.71M | 310.88%130.8M | 274.68%51.73M | 559.33%11.25M | -403.68%-36.4M | -44.63%31.83M | -69.44%13.81M |
| Fair value change income | -12.52%38.86M | -6.48%25.91M | 22.69%12.95M | 110.07%39.35M | 3,200.46%44.43M | 2,586.99%27.7M | 2,279.16%10.56M | 910.90%18.73M | 0.00%1.35M | 15.04%1.03M |
| Invest income | 228.64%501.15K | -63.81%927.29K | 187.12%3.81M | 458.97%25.95M | 94.38%-389.59K | 149.87%2.56M | -13.01%-4.38M | 69.56%-7.23M | -371.14%-6.93M | -377.43%-5.14M |
| -Including: Investment income associates | 17.25%-8.28K | 36.95%-6.21K | ---2.9K | -404.37%-15.06K | ---10.01K | ---9.85K | ---- | ---2.99K | ---- | ---- |
| Asset deal income | -18.64%-1.76M | -3.21%-982.25K | 54.61%-58.22K | 73.67%-819.3K | 49.88%-1.49M | 63.18%-951.69K | 71.35%-128.28K | -23.64%-3.11M | -284.25%-2.96M | -267.27%-2.58M |
| Other revenue | -59.64%46.27M | -28.62%29.32M | 11.81%20.32M | 117.58%175.28M | 143.85%114.65M | 42.60%41.07M | 208.31%18.17M | -21.58%80.56M | -20.91%47.01M | -36.53%28.8M |
| Operating profit | -66.97%703.13M | -65.39%670.96M | -73.13%391.39M | -37.10%1.78B | 21.25%2.13B | 48.93%1.94B | 149.70%1.46B | 80.33%2.83B | 21.02%1.76B | 13.39%1.3B |
| Add:Non operating Income | -35.27%2.5M | -56.54%1.2M | -47.76%826.48K | 0.86%8.44M | -10.37%3.86M | 102.52%2.76M | 113.72%1.58M | -23.37%8.37M | -50.36%4.31M | -69.39%1.36M |
| Less:Non operating expense | 26.58%33.52M | 273.18%28.84M | 949.44%23.77M | 81.66%104.06M | -51.71%26.48M | -77.36%7.73M | -84.80%2.26M | 118.02%57.28M | 314.46%54.85M | 210.17%34.13M |
| Total profit | -68.09%672.11M | -66.73%643.32M | -74.70%368.46M | -39.43%1.68B | 23.52%2.11B | 52.38%1.93B | 155.79%1.46B | 78.97%2.78B | 17.91%1.71B | 11.17%1.27B |
| Less:Income tax cost | -65.07%123.02M | -64.67%116.7M | -73.88%66.54M | -19.62%339.91M | 20.19%352.15M | 49.14%330.34M | 196.95%254.75M | 99.39%422.87M | 31.20%292.99M | 25.13%221.5M |
| Net profit | -68.69%549.09M | -67.15%526.63M | -74.87%301.92M | -42.98%1.34B | 24.21%1.75B | 53.07%1.6B | 148.48%1.2B | 75.74%2.36B | 15.48%1.41B | 8.61%1.05B |
| Net profit from continuing operation | -68.69%549.09M | -67.15%526.63M | -74.87%301.92M | -42.98%1.34B | 24.21%1.75B | 53.07%1.6B | 148.48%1.2B | 75.74%2.36B | 15.48%1.41B | 8.61%1.05B |
| Less:Minority Profit | -19.85%-5.69M | -28.95%-3.83M | -86.37%-2.01M | -62.08%-8.08M | -115.41%-4.75M | -127.02%-2.97M | -33.20%-1.08M | -124.08%-4.98M | -153.12%-2.2M | -1,137.88%-1.31M |
| Net profit of parent company owners | -68.46%554.78M | -66.97%530.46M | -74.73%303.93M | -42.76%1.35B | 24.35%1.76B | 53.16%1.61B | 148.29%1.2B | 75.82%2.36B | 15.58%1.41B | 8.76%1.05B |
| Earning per share | ||||||||||
| Basic earning per share | -68.45%0.3321 | -66.97%0.3175 | -74.73%0.1819 | -42.76%0.8095 | 24.36%1.0527 | 53.17%0.9613 | 148.21%0.7198 | 75.81%1.4142 | 15.58%0.8465 | 8.75%0.6276 |
| Diluted earning per share | -68.45%0.3321 | -66.97%0.3175 | -74.73%0.1819 | -42.76%0.8095 | 24.36%1.0527 | 53.17%0.9613 | 148.21%0.7198 | 75.81%1.4142 | 15.58%0.8465 | 8.75%0.6276 |
| Other composite income | -38.27%551.88K | -97.93%20.58K | -109.64%-33.17K | -75.74%604.59K | -60.16%894.04K | -7.73%993.76K | 308.67%344.14K | 495.75%2.49M | 1,580.59%2.24M | 690.49%1.08M |
| Other composite income of parent company owners | -38.27%551.88K | -97.93%20.58K | -109.64%-33.17K | -75.74%604.59K | -60.16%894.04K | -7.73%993.76K | 308.67%344.14K | 495.75%2.49M | 1,580.59%2.24M | 690.49%1.08M |
| Total composite income | -68.68%549.64M | -67.17%526.65M | -74.88%301.89M | -43.02%1.34B | 24.07%1.75B | 53.01%1.6B | 148.64%1.2B | 76.01%2.36B | 15.65%1.41B | 8.74%1.05B |
| Total composite income of parent company owners | -68.44%555.33M | -66.99%530.48M | -74.74%303.89M | -42.80%1.35B | 24.21%1.76B | 53.10%1.61B | 148.45%1.2B | 76.09%2.37B | 15.75%1.42B | 8.89%1.05B |
| Total composite income of minority owners | -19.85%-5.69M | -28.95%-3.83M | -86.37%-2.01M | -62.08%-8.08M | -115.41%-4.75M | -127.02%-2.97M | -33.20%-1.08M | -124.08%-4.98M | -153.12%-2.2M | -1,137.88%-1.31M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Zhongqin Wanxin Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Zhongqin Wanxin Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
